These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6497765)
41. The natural history of Parkinson's disease. Selby G Aust Fam Physician; 1984 May; 13(5 Suppl):1-3. PubMed ID: 6497764 [No Abstract] [Full Text] [Related]
42. PET studies on the early and differential diagnosis of Parkinson's disease. Brooks DJ Neurology; 1993 Dec; 43(12 Suppl 6):S6-16. PubMed ID: 8264913 [TBL] [Abstract][Full Text] [Related]
43. Background scenery visual hallucinations in a depressed patient with Parkinson's disease. Kataoka H; Inoue M; Ueno S Mov Disord; 2010 Apr; 25(6):786-7. PubMed ID: 20131385 [No Abstract] [Full Text] [Related]
44. Parkinson's: symptoms, treatments and research. Heisters D Br J Nurs; 2011 May 13-26; 20(9):548-54. PubMed ID: 21647015 [TBL] [Abstract][Full Text] [Related]
45. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease. Nagamine T Asian J Psychiatr; 2020 Apr; 50():102031. PubMed ID: 32272360 [No Abstract] [Full Text] [Related]
47. The management of Parkinson's disease. Pentland B Geriatr Nurs Home Care; 1988 Jan; 8(1):12-4. PubMed ID: 3345912 [No Abstract] [Full Text] [Related]
48. Diagnosis and treatment of Parkinson's disease in the elderly. Sage JI; Mark MH J Gen Intern Med; 1994 Oct; 9(10):583-9. PubMed ID: 7823231 [No Abstract] [Full Text] [Related]
50. Antidyskinetic actions of amantadine in Parkinson's disease: are benefits maintained in the long term? Brotchie J Expert Rev Neurother; 2010 Jun; 10(6):871-3. PubMed ID: 20518602 [No Abstract] [Full Text] [Related]
51. 4th Symposium on a Long Term Clinical Care of Parkinson's Disease. Tokyo, April 22, 1989. Proceedings. Eur Neurol; 1990; 30 Suppl 1():1-40. PubMed ID: 2311635 [No Abstract] [Full Text] [Related]
52. [Centers for the management of Parkinson's disease]. Brefel-Courbon C; Rémy P Rev Prat; 2018 May; 68(5):520-521. PubMed ID: 30869417 [No Abstract] [Full Text] [Related]
53. The impact of treatment with levodopa on Parkinson's disease. Shaw KM; Lees AJ; Stern GM Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763 [TBL] [Abstract][Full Text] [Related]
54. Treatment of Parkinson's disease: levodopa as the first choice. Katzenschlager R; Lees AJ J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059 [TBL] [Abstract][Full Text] [Related]
56. Parkinson's disease in 1984: an update. Lang AE; Blair RD Can Med Assoc J; 1984 Nov; 131(9):1031-7. PubMed ID: 6388779 [TBL] [Abstract][Full Text] [Related]
57. Difficulties in long term management of Parkinson's disease. Burns R Aust Fam Physician; 1984 May; 13(5 Suppl):14-6. PubMed ID: 6497765 [TBL] [Abstract][Full Text] [Related]
58. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]